Vivesto AB Reports Positive Topline Data for Paccal Vet in Dogs
Vivesto reported positive topline results in 26 dogs with Stage I—II splenic hemangiosarcoma post-splenectomy, showing median overall survival of 135 days with Paccal Vet. Data support moving to a pivotal study; four dogs remain in follow-up and final results are expected by year-end.Material Detai…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.